Division of Cardiology, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 1049, Baltimore, MD 21205, USA.
J Cardiovasc Transl Res. 2008 Jun;1(2):144-54. doi: 10.1007/s12265-008-9025-1. Epub 2008 Apr 22.
Hereditary forms of hypertrophic, dilated, restrictive, and right ventricular cardiomyopathies are frequently seen. Patterns of inheritance include autosomal dominant, autosomal recessive, X-linked, and matrilinear. Recognition of the mode of inheritance facilitates proper clinical screening of family members in subsequent generations. Report of successful sequence analysis of the human genome 7 years ago has resulted in widespread translation of genomic information into clinical applications. As technologic advances in high throughput sequence determination continue to evolve, an era of personalized medicine based on genomic data is highly anticipated. Today, clinical genetic testing is available for most monogenic forms of cardiomyopathy and the demand among patients and families is increasing. However, physicians and patients should consider the benefits and limitations of such testing. This review will focus on inherited forms of cardiomyopathy, detailing the currently available genetic tests, as well as benefits, limitations, and possible outcomes of such testing.
遗传性肥厚型、扩张型、限制型和右心室心肌病经常可见。遗传模式包括常染色体显性遗传、常染色体隐性遗传、X 连锁遗传和母系遗传。对遗传模式的认识有助于在后代中对家族成员进行适当的临床筛查。7 年前人类基因组测序的成功报告导致基因组信息广泛应用于临床。随着高通量测序技术的不断进步,基于基因组数据的个体化医疗时代备受期待。如今,大多数单基因形式的心肌病都可以进行临床基因检测,而且患者和家属的需求也在不断增加。然而,医生和患者都应该考虑这种检测的益处和局限性。本综述将重点介绍遗传性心肌病,详细介绍目前可用的基因检测方法,以及这种检测的益处、局限性和可能的结果。